《藥物經濟學與結果研究專家評論》(ISSN 1473-7167)提供有關藥物臨床使用和治療方法的成本效益和藥物經濟學問題的專家評論。涵蓋范圍包括藥物經濟學和生活質量研究，治療結果，循證醫(yī)學和成本效益研究。所有的文章都要經過嚴格的同行評審。該雜志采用獨特的專家評論文章格式，提供了一個關鍵技術領域、研究或臨床實踐的當前思想的完整概述，并輔以以下章節(jié):專家評論-對最有效或最有前途的策略的個人觀點五年展望——在一個現實的時間尺度內對未來前景的清晰展望關鍵問題-執(zhí)行摘要削減到作者最關鍵的觀點

Expert Review of Pharmacoeconomics & Outcomes Research (ISSN 1473-7167) provides expert reviews on cost-benefit and pharmacoeconomic issues relating to the clinical use of drugs and therapeutic approaches. Coverage includes pharmacoeconomics and quality-of-life research, therapeutic outcomes, evidence-based medicine and cost-benefit research. All articles are subject to rigorous peer-review. The journal adopts the unique Expert Review article format, offering a complete overview of current thinking in a key technology area, research or clinical practice, augmented by the following sections: Expert Commentary - a personal view on the most effective or promising strategiesFive-year view - a clear perspective of future prospects within a realistic timescaleKey issues - an executive summary cutting to the author's most critical points